Jefferies Group’s Celldex Therapeutics CLDX Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2022
Q3 | – | Sell |
-59,098
| Closed | -$1.59M | – | 1188 |
|
2022
Q2 | $1.59M | Buy |
59,098
+54,348
| +1,144% | +$1.47M | 0.01% | 360 |
|
2022
Q1 | $162K | Sell |
4,750
-2,750
| -37% | -$93.7K | ﹤0.01% | 833 |
|
2021
Q4 | $290K | Buy |
+7,500
| New | +$290K | ﹤0.01% | 793 |
|
2021
Q3 | – | Hold |
0
| – | – | – | 1121 |
|
2021
Q2 | – | Sell |
-25,637
| Closed | -$528K | – | 1140 |
|
2021
Q1 | $528K | Buy |
+25,637
| New | +$528K | ﹤0.01% | 696 |
|
2020
Q4 | – | Hold |
0
| – | – | – | 1011 |
|
2020
Q3 | – | Hold |
0
| – | – | – | 883 |
|
2018
Q3 | – | Sell |
-18,621
| Closed | -$141K | – | 1655 |
|
2018
Q2 | $141K | Buy |
+18,621
| New | +$141K | ﹤0.01% | 1388 |
|
2016
Q1 | – | Sell |
-977
| Closed | -$230K | – | 1325 |
|
2015
Q4 | $230K | Buy |
+977
| New | +$230K | ﹤0.01% | 1014 |
|
2015
Q3 | – | Sell |
-2,807
| Closed | -$1.06M | – | 1425 |
|
2015
Q2 | $1.06M | Sell |
2,807
-178
| -6% | -$67.3K | 0.01% | 564 |
|
2015
Q1 | $1.25M | Buy |
+2,985
| New | +$1.25M | 0.01% | 447 |
|
2014
Q2 | – | Sell |
-4,316
| Closed | -$1.14M | – | 1422 |
|
2014
Q1 | $1.14M | Buy |
+4,316
| New | +$1.14M | 0.01% | 393 |
|
2013
Q3 | – | Sell |
-7
| Closed | -$2K | – | 1253 |
|
2013
Q2 | $2K | Buy |
+7
| New | +$2K | ﹤0.01% | 1168 |
|